HIBIO is determined to become an advanced large-scale and excellent provider of scientific research outsourcing services in the field of biomedicine in China. It is committed to providing all-round preclinical research services for pharmaceutical enterprises, research institutions and all scientific researchers in the world, and promoting the research and development process of biomedical industry. Service content: Animal model replication: it has established SPF and clean animal laboratories, which can independently carry out animal modeling including mice, nude mice, guinea pigs, rabbits, Beagle dogs, sheep, miniature pigs and other common experimental animals, and has mastered more than 100 different types of animal model replication methods. Preclinical research: drug screening, drug efficacy evaluation, drug safety evaluation, pharmacokinetic services, preclinical research of medical devices and stem cells, etc Histopathological examination: HE staining, special staining, immunohistochemistry, immunofluorescence, TUNEL, in situ hybridization, transmission electron microscopy, scanning electron microscopy, etc
Cell biology services: primary cell culture, cell lines, cell transfection, Transwell, flow cytometry detection, dendritic cells, stem cell culture, magnetic bead sorting, etc Molecular biological detection: CRISPR/Cas9 knockout technology service, fluorescence quantitative PCR, laser confocal detection, viral vector construction and packaging, SNP typing service, EMSA gel / electrophoresis mobility test service, carrier construction, site directed mutation service, chromatin immunoprecipitation, dual luciferase reporter gene service, Western Blot, DNA methylation detection, etc.